Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K

Jan-09

AUTHORS : Gerry Oster, Policy Analysis Inc. (PAI), 822 Boylston Street, Suite 206, Chestnut Hill, MA 02467 – Email: goster@pai2.com / info@pai2.com – Profile: https://pai2.com/about-us/partners/gerry-oster-ph-d/

JOURNAL : Pain Practice

REFERENCE: 9(1):18-34

DOI : 10.1111/j.1533-2500.2008.00226.x

Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K

More publications

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Prodromal Parkinson’s disease and subsequent risk of Parkinson’s disease and mortality